Offer - Urjas Oil for just Rs 1 X
Aycin 500 Injection is a prescription drug, available for use as Injection. Urinary Tract Infection are some of its major therapeutic uses. Other than this, Aycin 500 Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Aycin 500 Injection depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Some other side effects of Aycin 500 Injection have been listed ahead. Such side effects of Aycin 500 Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Aycin 500 Injection's effect is Severe during pregnancy and Unknown for lactating mothers. It is important to know if Aycin 500 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Aycin 500 Injection related warnings section.
Aycin 500 Injection is contraindicated in people with pre-existing medical conditions like Dehydration, Parkinson's Disease, Hearing Loss as it can result in adverse effects. The section on Aycin 500 Injection contraindications lists all such conditions.
Drug reaction of Aycin 500 Injection with other medicines has been reported. See below for a complete list.
You should also be aware that Aycin 500 Injection is safe while driving, and is addiction.
Aycin 500 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Is the use of Aycin 500 Injection safe for pregnant women?
Aycin can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Aycin 500 Injection safe during breastfeeding?
No research work has been carried out till date on effect of Aycin on breastfeeding women. So it is not known whether taking Aycin will cause side effects or not.
What is the effect of Aycin 500 Injection on the Kidneys?
Aycin may have severe effects on your kidney, so do not take it without consulting your doctor.
What is the effect of Aycin 500 Injection on the Liver?
Aycin is rarely harmful for the liver.
What is the effect of Aycin 500 Injection on the Heart?
Very few cases of side effects of Aycin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Aycin 500 Injection unless your doctor advises you to do so -
Is this Aycin 500 Injection habit forming or addictive?
Aycin 500 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Aycin 500 Injection as it does not make you drowsy.
Is it safe?
Aycin 500 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Aycin 500 Injection for mental disorders.
Interaction between Food and Aycin 500 Injection
Taking Aycin 500 Injection with food is safe.
Interaction between Alcohol and Aycin 500 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Aycin 500 Injection.
Aycin is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Yes, Aycin is effective against bacteria (Pseudomonas). But it is also found that Pseudomonas can get resistant to this drug and in that case Aycin will not produce desired results. If you are experiencing no symptomatic relief after taking this medicine then inform your doctor and follow his/her instructions.
No, Aycin cannot be taken with penicillin. Because penicillin inactivates the Aycin by combining the beta-lactam ring of penicillin with an amino group of this drug to form amide which is biologically inactive. For this reason Aycin should not be taken with penicillin. The chances of inactivation of this drug are higher in case of renal failure because in this case concentration of penicillin is higher in the kidney for a longer time as compared to the normal renal function.
Yes, Aycin is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
No, Aycin is not available in tablet form. It is available in only injectable dosage form either given by intramuscularly or intravenously depends on patient condition or severity of infections.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137